International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

Interview with Jiangtao Tang

JTang

This month we hear from Jiangtao Tang from the West China Hospital, who shares about the challenges they are overcoming at his centre switching from immunoassay to mass spectrometry based assays and automation of sample pre-processing.  Jiangtao further shares his vision how metabolomics and proteomics, together with bioinformatics, will optimize patient care.

 

Jiangtao Tang
Department of Clinical Immunological Laboratory, West China Hospital

Sichuan University, Chengdu, CN

Interview with Teun van Gelder

Teun van Gelder

This month our current President, Teun van Gelder, shares his vision for his term, in particular increasing involvement of prescribers with the activities of the Association and research in the field. We also hear about Teun’s dual role at the Erasmus Medical Centre, and the collaboration between several prominent IATDMCT members that bring together various disciplines to daily patient care.

 

Teun van Gelder
Internist-nephrologist, Department of Internal Medicine
Internist-clinical pharmacologist, Hospital Pharmacy Department
Erasmus Medical Center, Rotterdam, NL

Interview with Loralie Langman

Loralie Langman

This month we hear from our recent Past-President, Loralie Langman, who shares with us a few reflections about her time as President, her passion for the field and a few innovative technologies used in her place of practice, spanning clinical and forensic toxicology, TDM, and pharmacogenetics.

 

Loralie Langman
Director, Department of Laboratory Medicine and Pathology
Mayo Clinic, Rochester, MN, USA

Interview with William Clarke

TDMO Clarke ViceChair 150x200

This month we return to our interviews, and hear from Professor William Clarke, Chair of the TDM in Oncology committee. Alongside academic and clinical work, Professor Clarke is involved in an academic initiative in disposable microfluidic diagnostics, which has potential to impact the clinical application of TDM in resource limited settings.

 

William Clarke
Associate Professor, Pathology
Johns Hopkins School of Medicine, Baltimore, Maryland, USA

Page 2 of 12

The content of the IATDMCT Blog does not necessarily have the endorsement of the Association.